• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Self-reported efficacy of complementary and alternative medicine: the Akershus study of chronic headache.
CONCLUSION: CAM is widely used, despite self-reported efficacy of different CAM modalities is modest in the management of chronic headache. PMID: 23596996 [PubMed - indexed for MEDLINE]
Source: Pain Physician - September 30, 2013 Category: Anesthesiology Authors: Kristoffersen ES, Aaseth K, Grande RB, Lundqvist C, Russell MB Tags: J Headache Pain Source Type: research

Magnesium in depression.
Abstract Magnesium is one of the most essential mineral in the human body, connected with brain biochemistry and the fluidity of neuronal membrane. A variety of neuromuscular and psychiatric symptoms, including different types of depression, was observed in magnesium deficiency. Plasma/serum magnesium levels do not seem to be the appropriate indicators of depressive disorders, since ambiguous outcomes, depending on the study, were obtained. The emergence of a new approach to magnesium compounds in medical practice has been seen. Apart from being administered as components of dietary supplements, they are also perc...
Source: Pharmacological Reports - August 23, 2013 Category: Drugs & Pharmacology Authors: Serefko A, Szopa A, Wlaź P, Nowak G, Radziwoń-Zaleska M, Skalski M, Poleszak E Tags: Pharmacol Rep Source Type: research

Prescription of Complementary and Alternative Medicine (CAM) in an Italian Cohort of Pediatric Headache Patients (P03.115)
CONCLUSIONS: Our study shows that CAM is widely used among pediatric headache patients, and physicians are mostly unaware of prescription. Further studies are required to investigate safety and efficacy of CAM, as a possible side-medicine to conventional pharmacological approach.Disclosure: Dr. Colombo has nothing to disclose. Dr. Dalla Libera has nothing to disclose. Dr. Pavan has nothing to disclose. Dr. Comi has received personal compensation for activities with Novartis, Teva Neuroscience, Sanofi-Aventis Pharmaceuticals, Inc., Merck Serono, and Bayer Schering.
Source: Neurology - February 14, 2013 Category: Neurology Authors: Colombo, B., Dalla Libera, D., Pavan, G., Comi, G. Tags: P03 Headache: Epidemiology Source Type: research

Pages: 1  2  3